CD8A and cancer: Here we reveal that the glycosylated K‐TM subunit in T cells and sera of cancer patients is a crucial viral immune checkpoint (VIC) that induces CD8+ T cell anergy via directly targeting CD3ε and disabling TCR signaling and enabling cancer cells to escape immunosurveillance.